Chronic Infantile Neurological Cutaneous Articular syndrome
Active Research Protocols
- 03-AR-0173 – Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)
- 03-AR-0298 – A Long-Term Outcome Study with the IL-1 Receptor Antagonist anakinra/Kineret¨ in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of this Disease
- 05-AR-0014 – Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis
- 09-AR-0006 – A Multi-Center, Open Label, 24-Month Treatment Study to Establish the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of Canakinumab (anti-IL-1 Beta Antibody) in Patients with NOMID / CINCA Syndrome
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014